If you have been reading about incretin and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Development began in the 2010s, when researchers modified a GIP-based scaffold to add GLP-1 activity and then attached the fatty diacid to lengthen its half-life. Clinical evaluation proceeded through large phase 3 programmes in type 2 diabetes and in obesity, and regulators in the United States cleared the compound for type 2 diabetes in 2022 and for chronic weight management in 2023. Several cardiovascular and metabolic outcome studies are still reporting, so the picture of long-term benefit and risk is incomplete. Approvals in other regions followed on different timelines.
Tirzepatide is a synthetic peptide of 39 amino acids that carries a C20 fatty diacid side chain attached through a linker. Its molecular formula is C225H348N48O68, and its molecular weight is about 4813 daltons. The compound belongs to the incretin mimetic class and is administered by subcutaneous injection. The fatty acid chain promotes binding to serum albumin, which slows renal clearance and extends the circulation time of the molecule. It was identified during screening of sequences derived from glucose-dependent insulinotropic polypeptide.
Storage recommendations for tirzepatide generally specify refrigeration at 2–8 °C to maintain stability. The peptide should be protected from light and kept in its original packaging to prevent aggregation or adsorption. Freezing is not recommended because freeze-thaw cycles can cause aggregation or precipitation. Once dispensed, storage conditions and in-use periods follow product-specific labeling, which may allow room temperature storage for a limited time.
Degradation pathways for tirzepatide include deamidation, oxidation, and aggregation, which are common for therapeutic peptides. These processes can be monitored by size-exclusion chromatography (SEC) for aggregates and ion-exchange chromatography for charge variants. Forced degradation studies under acidic, basic, oxidative, and thermal stress help identify potential impurities. The exact stability profile depends on formulation, concentration, and container-closure system.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Peptide backbone with a fatty diacid chain |
| Molecular weight | About 4813 Da | Calculated from the formula |
| Receptor targets | GIP and GLP-1 receptors | Dual agonist activity at both sites |
| Route of administration | Subcutaneous injection | No approved oral form at present |
| Elimination half-life | About 5 days | Supports extended intervals between administrations |
In clinical research, tirzepatide has been studied in randomized controlled trials for glycemic control and body weight reduction. These trials typically measure changes in hemoglobin A1c and body weight over periods of several months. The drug is administered by subcutaneous injection, and its pharmacokinetic profile supports once-weekly dosing. Post-marketing surveillance continues to evaluate long-term outcomes and rare adverse events.
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
Like most synthetic peptides of this size, the material is commonly supplied as a lyophilised powder that appears white to off-white. It dissolves in aqueous buffers and in mixtures of water with a small proportion of organic solvent, though the fatty acid portion reduces solubility in pure water relative to short peptides. Hygroscopic behaviour is reported for many peptide powders, so weighing is usually performed quickly and under controlled humidity. Working solutions are typically prepared fresh and kept cold.
Long-term storage of lyophilised peptide powder is generally at minus twenty degrees Celsius or colder, with desiccant and protection from light. Short-term storage at two to eight degrees Celsius is common during active use. In solution, stability depends strongly on pH, concentration, and the presence of preservatives, and hydrolysis or aggregation can develop over weeks. Published stability data specific to this molecule are limited, so recommended conditions for research material are usually extrapolated from general peptide handling practice rather than from a dedicated study.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
Recommended storage for reference material is a freezer at approximately -20 degrees Celsius, protected from light and moisture. Commercial injectable presentations are stored refrigerated between 2 and 8 degrees Celsius and must not be frozen. Product labelling generally permits a limited period at controlled room temperature once dispensed, with the exact window depending on the presentation. Repeated temperature cycling is avoided because it can promote aggregation or deamidation of the peptide chain.
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, with mass confirmation by electrospray ionisation mass spectrometry. Peptide mapping after enzymatic digestion verifies the primary sequence. Size-exclusion chromatography quantifies aggregates, while circular dichroism provides a secondary-structure fingerprint. Bioanalytical quantification in plasma uses immunoassay or LC-MS/MS. Reported purity for research-grade lots is commonly 95 percent or higher, and residual water content is checked by Karl Fischer titration.
As a peptide, tirzepatide is handled as a lyophilised solid in research settings and as a preserved solution in finished products. Aqueous solubility is pH dependent and reaches a minimum near the isoelectric point, which lies close to pH 5.4. Stock solutions are typically prepared in neutral or slightly basic buffer to limit precipitation. The solid is hygroscopic and should be equilibrated to room temperature before opening so that condensation does not form on the powder surface.
Airband – Half-duplex radio system used by aircraft pilots to talk to other aircraft and ground-based air traffic controllers. This vital system is the main communication channel for air traffic control. For most communication in overland flights in air corridors a VHF-AM system using channels between 108 and 137 MHz in the VHF band is used. This system has a typical transmission range of 200 miles (320 km) for aircraft flying at cruising altitude. For flights in more remote areas, such as transoceanic airline flights, aircraft use the HF band or channels on the Inmarsat or Iridium satphone satellites. Military aircraft also use a dedicated UHF-AM band from 225.0 to 399.95 MHz.
A gas panel or gas manifold is the control equipment for supplying the breathing gas to the divers. Primary and reserve gas is supplied to the panel through shutoff valves from a low-pressure compressor or high-pressure storage cylinders ("bombs", "bundles", "quads", or "kellys"). The gas pressure may be controlled at the panel by an industrial pressure regulator, or it may already be regulated closer to the source (at the compressor, or at the storage cylinder outlet). The supply gas pressure is monitored on a gauge at the panel, and an over-pressure valve is fitted in case the supply pressure is too high. The gas panel may be operated by the diving supervisor if the breathing gas is air or a fixed ratio premix, but if the composition must be controlled or monitored during the dive it is usual for a dedicated gas panel operator, or "gas man" to do this work. There is a set of valves and gauges for each diver to be supplied from the panel. These include:
== Metabolism == Levamisole is readily absorbed from the gastrointestinal tract and metabolized in the liver. Its time to peak plasma concentration is 1.5–2 hours. The plasma elimination half-life is fairly quick at 3–4 hours which can contribute to not detecting levamisole intoxication. The metabolite half-life is 16 hours. Levamisole's excretion is primarily through the kidneys, with about 70% being excreted over 3 days. Only about 5% is excreted as unchanged levamisole. Drug testing of racehorse urine has led to the revelation that among levamisole equine metabolites are both pemoline and aminorex, stimulants that are forbidden by racing authorities. Further testing confirmed aminorex in human and canine urine, meaning that both humans and dogs also metabolize levamisole into aminorex, though it is unclear whether plasma aminorex is present at any appreciable level. Blood samples following oral administration of levamisole out to 172 hr post-dose did not demonstrate any plasma aminorex levels above that of the limit of quantification (LoQ). Additionally, in cocaine-positive plasma samples, of which 42% contained levamisole, aminorex was never reported at concentrations higher than LoQ.
At the same time, he joined Gehrig and Bill Terry as the only first basemen in MLB history to have at least a .315 batting average in eight consecutive seasons. Also in 2005, St. Louis Cardinals radio broadcaster Wayne Hagin claimed manager Don Baylor said that Helton had "tried the juice" in the 1990s, implying steroid use. Helton vehemently denied the allegation and considered legal action against Hagin. Hagin later apologized, claiming that his comments were "referring to supplements, creatine, not steroids", when he said "juiced". Baylor said of his conversation with Hagin, "We discussed creatine and that was the end of the conversation. Steroid use was never even a question with me in regards to Todd Helton. [Hagin] has his facts wrong." The following season, Helton again missed some time with an injury. He was on the disabled list from April 20 to May 4, having been diagnosed with acute terminal ileitis. For the season, he hit .302 with 15 home runs, 81 RBI, 40 doubles, 91 walks, to go with a .404 on-base percentage. He ended the season below .900 in OPS (with a .880 OPS) for the first time since entering the league in 1997, which was a year in which he had he only 35 games. Helton finished third on the team in runs (94), hits (165), doubles (40), total bases (260), and multi-hit games (42).
Sources: en.wikipedia.org
The chronic kidney disease of the cat (CKD or CNE)—also called chronic renal insufficiency (CRI or CNI) or chronic renal failure (CRF) in the older literature—is an incurable, progressive disease characterized by a gradual decrease in the nephrons and thus to a decreasing function (insufficiency) of the kidneys. It is one of the most common causes of death in older domestic cats. In current literature, the term "kidney disease" is preferred to the term "renal insufficiency" because the disease initially progresses without any measurable decline in kidney function. Due to the different type of diet and the resulting metabolic peculiarities, the clinical picture and treatment sometimes differ significantly from chronic renal failure in humans. Chronic kidney disease occurs in cats as a result of inflammation of the renal tubules and the renal interstitial tissue without an identifiable cause (idiopathic tubulointerstitial nephritis). The main symptoms are a reluctance to eat, increased drinking, increased urine output, fatigue, vomiting and weight loss. Chronic kidney disease in cats is divided into four main stages based on the creatinine concentration in the blood plasma, which are further subdivided according to the protein-creatinine quotient in the urine and blood pressure. Treatment is mainly based on reducing the protein and phosphate content of the diet to the basic requirement ("renal diet").
Bombesin is a 14-amino acid peptide originally isolated from the skin of the European fire-bellied toad (Bombina bombina) by Vittorio Erspamer et al. and named after its source. It has two known homologs in mammals called neuromedin B and gastrin-releasing peptide. It stimulates gastrin release from G cells. It activates three different G-protein-coupled receptors known as BBR1, -2, and -3. It also activates these receptors in the brain. Together with cholecystokinin, it is the second major source of negative feedback signals that stop eating behaviour. Bombesin is also a tumor marker for small cell carcinoma of lung, gastric cancer, pancreatic cancer, and neuroblastoma.
Romé de l'Isle's Essai de cristallographie published in 1772 and Cristallographie published in 1783 the scientific approach to crystal structure began. Romé de l'Isle described over 500 crystal forms and accurately measured the interfacial angles of a great variety of crystals, using the goniometer designed by his student Arnould Carangeot. Romé de l'Isle noted that the angles are characteristic of a substance, thus generalizing the law of constancy of angles postulated by Steno. Romé de l'Isle considered that the shape of a crystal is a consequence of the packing of elemental particles, and defined six primitive forms. In 1781 René Just Haüy (often termed the "Father of Modern Crystallography") discovered that crystals always cleave along crystallographic planes. Based on this observation, and the fact that the inter-facial angles in each crystal species always have the same value, Haüy concluded that crystals must be periodic and composed of regularly arranged layers of tiny polyhedra (molécules intégrantes). This theory explained why all crystal planes are related by small rational numbers (the law of rational indices). In 1784 René-Just Haüy published Essai d'une théorie sur la structure des cristaux, appliquée à plusieurs genres de substances cristallisées in which he stated his law of decrements: a crystal is composed of molecules arranged periodically in three dimensions without leaving any gaps. Haüy's molecular crystal structure theory assumed that molécules intégrantes were specific in shape and composition for every compound.
=== 8 March === EU ministers of defense agreed to purchase 1 billion euros worth of new artillery shells and provide another 1 billion euros worth of existing materials. Manufacturers needed larger orders to be financially secure enough to build new factories; new orders of artillery ammunition could take 2–3 years if produced using only the current factories. The US government was considering sending AIM-120 missiles to arm the Ukrainian Air Force's MiG-29 and Su-27.
== Challenges and criticisms == Critics of translational medical research (to the exclusion of more basic research) point to examples of important drugs that arose from fortuitous discoveries in the course of basic research such as penicillin and benzodiazepines, and the importance of basic research in improving our understanding of basic biological facts (e.g. the function and structure of DNA) that go on to transform applied medical research. Examples of failed translational research in the pharmaceutical industry include the failure of anti-aβ therapeutics in Alzheimer's disease. Other problems have stemmed from the widespread irreproducibility thought to exist in translational research literature.
Sources: en.wikipedia.org
It is a synthetic 39-amino-acid peptide that acts on two incretin receptors, the GIP receptor and the GLP-1 receptor. It is given by subcutaneous injection and has a circulating half-life of roughly five days. It is not a small molecule and is not absorbed usefully from the gut in conventional oral form.
Selective agents act on one receptor, while tirzepatide engages both GIP and GLP-1 receptors. The added GIP activity may contribute effects on insulin sensitivity and on fat metabolism. Whether the dual action produces meaningful clinical advantages beyond differences in potency is still being examined.
The downstream consequences of GIP receptor activation are not fully characterised in humans. It is also unclear how much each receptor contributes to appetite reduction and to shifts in body composition. Published work describes associations and proposed pathways rather than settled causal chains.
RP-HPLC is widely used for purity and impurity profiling. Mass spectrometry confirms identity.